Corrigendum: TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma

Yun-Zhu Zeng,Yong-Qu Zhang,Jiong-Yu Chen,Li-Ying Zhang,Wen-Liang Gao,Xue-Qiong Lin,Shao-Min Huang,Fan Zhang,Xiao-Long Wei

DOI: https://doi.org/10.3389/fonc.2021.767805

IF: 4.7

2021-10-06

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.627713.].

oncology

What problem does this paper attempt to address?

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Ru Zhou,Mahboubeh Yazdanifar,Lopamudra Das Roy,Lynsey M. Whilding,Artemis Gavrill,John Maher,Pinku Mukherjee

DOI: https://doi.org/10.3389/fimmu.2020.628776

IF: 7.3

2020-12-07

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2019.01149.].

immunology
Corrigendum: CORO1C is Associated with Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer

Zongxia Wang,Lizhou Jia,Yushu sun,Chunli Li,Lingli Zhang,Xiangcheng Wang,Hao Chen

DOI: https://doi.org/10.3389/fmolb.2021.727347

IF: 6.113

2021-08-30

Frontiers in Molecular Biosciences

Abstract:[This corrects the article DOI: 10.3389/fmolb.2021.682594.].

biochemistry & molecular biology
Corrigendum: GPER1 Silencing Suppresses the Proliferation, Migration, and Invasion of Gastric Cancer Cells by Inhibiting PI3K/AKT–Mediated EMT

En Xu,Xuefeng Xia,Chaoyu Jiang,Zijian Li,Zhi Yang,Chang Zheng,Xingzhou Wang,Shangce Du,Ji Miao,Feng Wang,Yizhou Wang,Xiaofeng Lu,Wenxian Guan

DOI: https://doi.org/10.3389/fcell.2022.841792

IF: 5.5

2022-01-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2020.591239.].
Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma

Meng-Xia Zhang,Li Wang,Lei Zeng,Zi-Wei Tu

DOI: https://doi.org/10.3389/fonc.2021.670714

IF: 4.7

2021-03-18

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.605777.].

oncology
Corrigendum: EXOSC5 As a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer Via Activating the ERK and AKT Pathways

Hongda Pan,Jingxin Pan,Shibo Song,Lei Ji,Hong Lv,Zhangru Yang

DOI: https://doi.org/10.3389/fonc.2021.670041

IF: 4.7

2021-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.00643.].
Corrigendum to “overexpression of GRK3, Promoting Tumor Proliferation, is Predictive of Poor Prognosis in Colon Cancer”

Tao Jiang,Chun Yang,Liyuan Ma,Zehua Wu,Ling Ye,Xiaoqiang Ma,Hai Li,Junwei Fan,Yinxue Yang

DOI: https://doi.org/10.1155/2020/1245645

2020-01-01

Disease Markers

Abstract:[This corrects the article DOI: 10.1155/2017/1202710.].
Corrigendum: Chloroquine Inhibits Stemness of Esophageal Squamous Cell Carcinoma Cells Through Targeting CXCR4-STAT3 Pathway

Dongli Yue,Daiqun Zhang,Xiaojuan Shi,Shasha Liu,Anqi Li,Dong Wang,Guohui Qin,Yu Ping,Yamin Qiao,Xinfeng Chen,Feng Wang,Renyin Chen,Song Zhao,Lidong Wang,Yi Zhang

DOI: https://doi.org/10.3389/fonc.2022.860158

IF: 4.7

2022-02-24

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.00311.].

oncology
Corrigendum: Multifunctions of CRIF1 in Cancers and Mitochondrial Dysfunction.

Yangzhou Jiang,Yang Xiang,Chuanchuan Lin,Weiwei Zhang,Zhenxing Yang,Lixin Xiang,Yanni Xiao,Li Chen,Qian Ran,Zhongjun Li

DOI: https://doi.org/10.3389/fonc.2023.1271492

IF: 4.7

2023-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.1009948.].
Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma

Yicong Yao,Yi Wang,Denglong Wu,Baoying Hu

DOI: https://doi.org/10.3389/fonc.2021.731942

IF: 4.7

2021-07-21

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.666418.].

oncology
Corrigendum: Brain Metastases from Esophageal Squamous Cell Carcinoma: Clinical Characteristics and Prognosis

Linlin Xiao,Yvonne M. Mowery,Brian G. Czito,Yajing Wu,Guangbin Gao,Chang Zhai,Jianing Wang,Jun Wang

DOI: https://doi.org/10.3389/fonc.2022.827810

IF: 4.7

2022-02-04

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.652509.].

oncology
Corrigendum: Anlotinib Combined with Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma

Jingzhen Shi,Ying-jie Zhang,Jin-zhi Wang,Jianbin Li,Zhenxiang Li

DOI: https://doi.org/10.3389/fonc.2020.583499

IF: 4.7

2020-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.00995.].
Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway

Xiaozhong Liao,Ying Gao,Jiahui Liu,Lan-Ting Tao,Dongmei Wang,Dan Xie,Sui‐Lin Mo

DOI: https://doi.org/10.3389/fonc.2021.670798

IF: 4.7

2021-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.01756/full.].
Corrigendum: Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach

Yee Kit Tai,Karen Ka Wing Chan,Charlene Hui Hua Fong,Sharanya Ramanan,Jasmine Lye Yee Yap,Jocelyn Naixin Yin,Yun Sheng Yip,Wei Ren Tan,Angele Pei Fern Koh,Nguan Soon Tan,Ching Wan Chan,Ruby Yun Ju Huang,Jing Ze Li,Jürg Fröhlich,Alfredo Franco-Obregón

DOI: https://doi.org/10.3389/fonc.2022.892408

IF: 4.7

2022-04-20

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.783803.].

oncology
Corrigendum: Negatively Regulated by Mir-29C-3p, MTFR1 Promotes the Progression and Glycolysis in Lung Adenocarcinoma Via the AMPK/mTOR Signalling Pathway.

Yongmeng Li,Yanfei Liu,Kai Jin,Rui Dong,Cun Gao,Libo Si,Zitong Feng,Huiying Zhang,Hui Tian

DOI: https://doi.org/10.3389/fcell.2022.870313

IF: 5.5

2022-01-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.771824.].
Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer

Xin Tian,Lina Wu,Min Jiang,Zhenyong Zhang,Rong Wu,Jianing Miao,Caigang Liu,Song Gao

DOI: https://doi.org/10.3389/fonc.2022.793448

IF: 4.7

2022-04-06

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.641399.].

oncology
Corrigendum: High expression of PARP1 in tumor and stroma cells predicts prognosis and platinum resistance in patients with advanced epithelial ovarian cancer

Wei-Wei Zuo,Chun-Fang Zhao,Yan Li,Hai-Yan Sun,Guo-Ming Ma,Yue-Ping Liu,Shan Kang

DOI: https://doi.org/10.3389/fonc.2023.1218746

IF: 4.7

2023-06-27

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.931445.].

oncology
Corrigendum: Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis via Regulation of the PI3K/AKT/mTOR Signaling Pathway

Jida Guo,Shengqiang Zhang,Jun Wang,Pengfei Zhang,Tong Lu,Linyou Zhang

DOI: https://doi.org/10.3389/fonc.2022.970020

IF: 4.7

2022-07-05

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.833719.].

oncology
Erratum: [corrigendum] Upregulation of LINC00659 Expression Predicts a Poor Prognosis and Promotes Migration and Invasion of Gastric Cancer Cells.

Pihai Gong,Ying Xu,Min Liu,Xiaohui Shen,Yuhang Mao,Yiping Li,Kun Zhang,Shenling Yu,Hong Fan

DOI: https://doi.org/10.3892/ol.2023.13785

2023-01-01

Oncology Letters

Abstract:[This corrects the article DOI: 10.3892/ol.2021.12818.].
Corrigendum: Association of preoperative NANOG-positive circulating tumor cell levels with recurrence of hepatocellular carcinoma

Yongrong Lei,Xishu Wang,Heng Sun,Yuna Fu,Yichen Tian,Ludi Yang,Jianhua Wang,Feng Xia

DOI: https://doi.org/10.3389/fonc.2024.1438731

2024-07-10

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.601668.].
Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer

Sen Miao,Gaoda Ju,Chonghua Jiang,Bing Xue,Lihua Zhao,Rui Zhang,Han Diao,Xingzhou Yu,Linlin Zhang,Xiaozao Pan,Hua Zhang,Lijuan Zang,Lei Wang,Tianhao Zhou

DOI: https://doi.org/10.3389/fmed.2024.1375203

IF: 3.9

2024-02-05

Frontiers in Medicine

Abstract:[This corrects the article DOI: 10.3389/fmed.2023.1167676.].

medicine, general & internal

Corrigendum: TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Corrigendum: CORO1C is Associated with Poor Prognosis and Promotes Metastasis Through PI3K/AKT Pathway in Colorectal Cancer

Corrigendum: GPER1 Silencing Suppresses the Proliferation, Migration, and Invasion of Gastric Cancer Cells by Inhibiting PI3K/AKT–Mediated EMT

Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma

Corrigendum: EXOSC5 As a Novel Prognostic Marker Promotes Proliferation of Colorectal Cancer Via Activating the ERK and AKT Pathways

Corrigendum to “overexpression of GRK3, Promoting Tumor Proliferation, is Predictive of Poor Prognosis in Colon Cancer”

Corrigendum: Chloroquine Inhibits Stemness of Esophageal Squamous Cell Carcinoma Cells Through Targeting CXCR4-STAT3 Pathway

Corrigendum: Multifunctions of CRIF1 in Cancers and Mitochondrial Dysfunction.

Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma

Corrigendum: Brain Metastases from Esophageal Squamous Cell Carcinoma: Clinical Characteristics and Prognosis

Corrigendum: Anlotinib Combined with Chemoradiotherapy Exhibits Significant Therapeutic Efficacy in Esophageal Squamous Cell Carcinoma

Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway

Corrigendum: Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach

Corrigendum: Negatively Regulated by Mir-29C-3p, MTFR1 Promotes the Progression and Glycolysis in Lung Adenocarcinoma Via the AMPK/mTOR Signalling Pathway.

Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer

Corrigendum: High expression of PARP1 in tumor and stroma cells predicts prognosis and platinum resistance in patients with advanced epithelial ovarian cancer

Corrigendum: Hinokiflavone Inhibits Growth of Esophageal Squamous Cancer By Inducing Apoptosis via Regulation of the PI3K/AKT/mTOR Signaling Pathway

Erratum: [corrigendum] Upregulation of LINC00659 Expression Predicts a Poor Prognosis and Promotes Migration and Invasion of Gastric Cancer Cells.

Corrigendum: Association of preoperative NANOG-positive circulating tumor cell levels with recurrence of hepatocellular carcinoma

Corrigendum: Identification of DYNLT1 associated with proliferation, relapse, and metastasis in breast cancer